While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
Jake Leach, Dexcom CEO, joins 'Closing Bell Overtime' to talk its 2026 outlook, the impact of GLP-1s, new devices and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback